Accessibility Menu
Fresenius Medical Care logo

Fresenius Medical Care(OTC) FMCQF

Market Cap$13.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-16%
5 Year-25%
1 Year+5%
1 Month+3%
$51.44
+3.25%
+1.62Today
Fresenius Medical Care last closing stock price
MetricPriceDate
Last closeUSD 51.442026-08-28
Fresenius Medical Care stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 51.442026-08-20
1 month+3.25%USD 49.822026-07-29
3 month+27.73%USD 40.272026-05-29
Year to date+15.32%USD 44.612025-12-18
1 year+5.19%USD 48.902025-08-28
3 year+13.98%USD 45.132023-08-23
5 year-25.3%USD 68.862021-08-27
Since inception-16.4%USD 61.532003-12-08

Fresenius Medical Care Financials at a Glance

Market Cap

$13.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€19.44B

Net Income (TTM)

€937.80M

EPS (TTM)

$3.88

P/E Ratio

13.27

Dividend

$1.73

Beta (Volatility)

0.07 (Low)

Price

$51.44

Volume

28

Open

$51.44

Previous Close

$51.44

Daily Range

$51.44 - $51.44

52-Week Range

$42.00 - $56.24

Estimated Earnings Date

Nov 3, 2026

FMCQF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fresenius Medical Care

Fresenius Medical Care AG is a leading provider of products and services for individuals with renal diseases. The company operates through two main segments: Care Enablement and Care Delivery, focusing on healthcare products and services for chronic kidney disease (CKD) and end-stage renal disease (ESRD).

Products and Services
  • Healthcare products for renal disease management
  • Dialysis services and treatment programs
  • Research and development in renal care technologies
Growth Outlook
  • Revenue of €4.85 billion in Q2 2026, showing strong demand
  • Operating income margin of 11.1% indicates operational efficiency
  • Continued investment in R&D to enhance product offerings
Financial Highlights
  • Net income of €217.67 million in Q2 2026, reflecting solid profitability
  • Trailing twelve months (TTM) revenue of €18.9 billion, showcasing growth
  • Dividend yield of 3.64% offers attractive returns for investors
Fresenius Medical Care AG stands out in the healthcare sector, particularly in renal care, with a robust portfolio of products and services. The company's recent financial performance highlights its ability to generate significant revenue and maintain profitability, making it an appealing option for potential investors. The focus on research and development ensures that Fresenius remains at the forefront of innovation in renal care, positioning the company for sustained growth in the future.
AI Generated • Aug 19, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

107,226

CEO

Helen Giza, MBA

Website

www.freseniusmedicalcare.com/de

Headquarters

Bad Homburg, HE 61352, DE

FMCQF Financials

Key Financial Metrics (TTM)

Gross Margin

26.36%

Operating Margin

10.69%

Net Income Margin

4.83%

Return on Equity

7.21%

Return on Capital

7.62%

Return on Assets

3.00%

Earnings Yield

7.54%

Dividend Yield

3.36%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

266.11M

Volume

28

Avg. Volume

552.5

Financials (TTM)

Gross Profit

€5.12B

Operating Income

€1.95B

EBITDA

€3.41B

Operating Cash Flow

€2.83B

Capital Expenditure

-€1.05B

Free Cash Flow

€1.79B

Cash & ST Invst.

€1.45B

Total Debt

€10.96B

Fresenius Medical Care Performance Analysis

Fresenius Medical Care annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 20,383,982,131-2.1%
20232023-12-31EUR 21,032,149,4313.2%
20242024-12-31EUR 20,917,464,341-0.5%
20252025-12-31EUR 22,161,735,1155.9%
Fresenius Medical Care sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.9%
Q42025-12-313.8%
Q12026-03-31-8.7%
Q22026-06-304.8%
Fresenius Medical Care annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 2.41-38.3%
20232023-12-31EUR 1.84-23.8%
20242024-12-31EUR 1.987.9%
20252025-12-31EUR 3.7991.2%
Fresenius Medical Care sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3022.1%
Q42025-12-3121.3%
Q12026-03-31-62.3%
Q22026-06-3088.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€4.85B

+1.3%

Gross Profit

€1.31B

+7.7%

Gross Margin

26.95%

N/A

Market Cap

$13.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$123.29K

N/A

Employees

111,024

N/A

Net Income

€217.67M

-3.4%

EBITDA

€843.66M

+2.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.45B

-33.8%

Total Debt

€10.96B

-0.6%

Accounts Receivable

€3.47B

+7.2%

Inventory

€2.33B

+16.8%

Long Term Debt

€8.64B

-8.3%

Short Term Debt

€2.33B

+45.0%

Return on Assets

3.00%

N/A

Return on Invested Capital

8.61%

N/A

Free Cash Flow

€619.90M

-0.1%

Operating Cash Flow

€860.30M

+11.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SBMFFSino Biopharmaceutical Limited
$0.74+0.00%
SNNUFSmith & Nephew plc
$15.48+0.00%
GIKLYGrifols, S.A.
$5.75+0.00%
SONVYSonova Holding AG
$57.86-1.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About FMCQF

What is the current price of Fresenius Medical Care?

Fresenius Medical Care is trading at $51.44 per share.

What is the 52-week range for Fresenius Medical Care?

Over the past 52 weeks, Fresenius Medical Care has traded between $42.00 and $56.24.

How much debt does Fresenius Medical Care have?

As of the most recent reporting period, Fresenius Medical Care reported total debt of €12.53B.

How much cash does Fresenius Medical Care have on hand?

Fresenius Medical Care reported €1.21B in cash and cash equivalents in its most recent financial results.

What is Fresenius Medical Care’s dividend yield?

Fresenius Medical Care currently has a dividend yield of 3.36%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services